Management of rapidly progressive glomerulonephritis

Richard Glassock; William L. Henrich

doi:10.3810/hp.2000.02.185

Management of rapidly progressive glomerulonephritis

Richard Glassock
, William L. Henrich

UT Health San Antonio

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

Original language	English (US)
Pages (from-to)	59-71
Number of pages	13
Journal	Hospital practice (Office ed.)
Volume	35
Issue number	2
DOIs	https://doi.org/10.3810/hp.2000.02.185
State	Published - Feb 15 2000

ASJC Scopus subject areas

General Medicine

Access to Document

10.3810/hp.2000.02.185

Cite this

@article{79cd92d73c7e4fd1832b7d617aa7885e,

title = "Management of rapidly progressive glomerulonephritis",

abstract = "Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85\%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.",

author = "Richard Glassock and Henrich, \{William L.\}",

year = "2000",

month = feb,

day = "15",

doi = "10.3810/hp.2000.02.185",

language = "English (US)",

volume = "35",

pages = "59--71",

journal = "Hospital practice (Office ed.)",

issn = "8750-2836",

publisher = "Mcgraw Hill",

number = "2",

}

TY - JOUR

T1 - Management of rapidly progressive glomerulonephritis

AU - Glassock, Richard

AU - Henrich, William L.

PY - 2000/2/15

Y1 - 2000/2/15

N2 - Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

AB - Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

UR - https://www.scopus.com/pages/publications/0034651919

UR - https://www.scopus.com/pages/publications/0034651919#tab=citedBy

U2 - 10.3810/hp.2000.02.185

DO - 10.3810/hp.2000.02.185

M3 - Article

C2 - 10689390

AN - SCOPUS:0034651919

SN - 8750-2836

VL - 35

SP - 59

EP - 71

JO - Hospital practice (Office ed.)

JF - Hospital practice (Office ed.)

IS - 2

ER -

Management of rapidly progressive glomerulonephritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this